Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Empro Group's enterprise value is $144.46 Mil.
Empro Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $1.52 Mil. Therefore, Empro Group's EV-to-EBITDA for today is 95.36.
The historical rank and industry rank for Empro Group's EV-to-EBITDA or its related term are showing as below:
EMPG's EV-to-EBITDA is not ranked *
in the Medical Distribution industry.
Industry Median: 8.49 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Empro Group's PE Ratio (TTM) for today is calculated as:
Empro Group's share price for today is $17.36.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Empro Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $0.093.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Empro Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Empro Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Empro Group EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Empro Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Empro Group's EV-to-EBITDA falls into.
Empro Group's current Enterprise Value is $144.46 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Empro Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $1.52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Empro Group (EMPG) has a EV-to-EBITDA of 95.36 as of Aug. 28, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Empro Group.
Is Empro Group's EV-to-EBITDA too high?
Empro Group's current EV-to-EBITDA is 95.36. The Medical Distribution industry median EV-to-EBITDA is 8.49. Empro Group's value of 95.36 is 1023.2% above this industry median. Overall, Empro Group has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Empro Group's EV-to-EBITDA compare to EDAP and OMI?
Empro Group's EV-to-EBITDA of 95.36 can be compared against companies in the Medical Distribution industry. The industry median EV-to-EBITDA is 8.49. Empro Group's value of 95.36 is 1023.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.49, based on 99 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Empro Group's current EV-to-EBITDA of 95.36 is 1023.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Empro Group. For the Medical Distribution industry, the median EV-to-EBITDA is 8.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Empro Group's current EV-to-EBITDA is 95.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Empro Group stock overvalued right now?
Empro Group (EMPG) has a current EV-to-EBITDA of 95.36. The current EV-to-EBITDA is 95.36 and 1023.2% above the Medical Distribution industry median of 8.49. Empro Group's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Empro Group (EMPG), the current EV-to-EBITDA is 95.36 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Address21, Jalan 15/23, Tiong Nam Industry Park, Shah Alam, SGR, MYS, 40200
Empro Group Inc operates in the Health and Beauty industry, focusing on enhancing well-being and confidence through a combination of skincare, cosmetics, healthcare products, and embroidery services. The company derives majority of its revenue from health care business segment involves trading and wholesaling of medical masks, COVID-19 test kits and related products.
28GF Score
Get the complete analysis for EMPG
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EMPG has been successfully added to your 
